NCT04789291View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 18, 2021

Primary Completion Date

August 7, 2021

Study Completion Date

August 7, 2021

Conditions
Healthy
Interventions
DRUG

BI 1595043

Single dose of 30 milligram (mg) BI 1595043 as film coated tablets (1x 5mg tablet and 1x 25mg tablet).

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY